Artemisinin derivative TPN10466 suppresses immune cell migration and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Sign Up to like & getrecommendations! Published in 2022 at "Cellular immunology"
DOI: 10.1016/j.cellimm.2022.104500
Abstract: Multiple sclerosis (MS) was one of the major conditions causing neurological dysfunction and was an incurable progressive central nervous system disease. Experimental autoimmune encephalomyelitis (EAE) was the most commonly used experimental model of MS. Artemisinin… read more here.
Keywords: eae; tpn10466; th17 differentiation; disease ... See more keywords